Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures.
about
Pregabalin add-on for drug-resistant partial epilepsyPregabalin for essential tremorPregabalin add-on for drug-resistant partial epilepsyThe Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic PotentialAntiepileptic Drug Treatment in Children with EpilepsyThe effects of antiepileptic drugs on cognitive functional magnetic resonance imagingThe effect of pregabalin on sensorimotor gating in 'low' gating humans and mice.Pregabalin versus gabapentin in partial epilepsy: a meta-analysis of dose-response relationships.Modeling longitudinal daily seizure frequency data from pregabalin add-on treatment.New generation antiepileptic drugs: what do they offer in terms of improved tolerability and safety?A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD)Comparative efficacy and tolerability of anti-epileptic drugs for refractory focal epilepsy: systematic review and network meta-analysis reveals the need for long term comparator trialsNegative effects of antiepileptic drugs on mood in patients with epilepsy.Latest approaches for the treatment of spasticity and autonomic dysreflexia in chronic spinal cord injuryPregabalin in childhood epilepsy: a clinical trial study.Comparative efficacy of zonisamide and pregabalin as an adjunctive therapy in children with refractory epilepsy.The cognitive impact of antiepileptic drugs.Exploratory polysomnographic evaluation of pregabalin on sleep disturbance in patients with epilepsyDrug resistance in epilepsy: putative neurobiologic and clinical mechanisms.Defining success in clinical trials--profiling pregabalin, the newest AED.Evaluate the Efficacy and Safety of Anti-Epileptic Medications for Partial Seizures of Epilepsy: A Network Meta-Analysis.Pregabalin: a new neuromodulator with broad therapeutic indications.Currently available antiepileptic drugs.Refractory epilepsy: clinical overview.Enriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review.Effects of pregabalin on smoking behavior, withdrawal symptoms, and cognitive performance in smokersPregabalin in the treatment of spasticity: a retrospective case series.Management of epilepsy in the elderly.Clinical perspectives on lacosamideAdverse antiepileptic drug effects: toward a clinically and neurobiologically relevant taxonomy.The role side effects play in the choice of antiepileptic therapy in brain tumor-related epilepsy: a comparative study on traditional antiepileptic drugs versus oxcarbazepine.Pregabalin in the management of partial epilepsyPlacebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: systematic review and meta-analysis.Pregabalin monotherapy in patients with partial-onset seizures: a historical-controlled trial.Adjunctive antiepileptic drugs in adult epilepsy: how the first add-on could be the last.Pharmacotherapy for children and adolescents with epilepsy.Factors determining response to antiepileptic drugs in randomized controlled trials. A systematic review and meta-analysis.The adverse event profile of pregabalin: a systematic review and meta-analysis of randomized controlled trials.Placebo-corrected efficacy of modern nonenzyme-inducing AEDs for refractory focal epilepsy: systematic review and meta-analysis.Targeting voltage-gated calcium channels: developments in peptide and small-molecule inhibitors for the treatment of neuropathic pain.
P2860
Q24197972-F522AB38-D4C5-407D-91CF-DB15C624BF8AQ24203614-E94D4960-E595-42AF-B1A7-E02E0FA45D05Q24242802-9AF66897-2440-46EE-9685-7E8589EF4CECQ26781422-FA1DE379-04D7-4081-AE3C-297A9DC3B101Q26781771-DE2EDB57-FCDA-4A40-A398-97D465D5BE8DQ27005706-6225FD01-54AF-4F30-A705-8B621EBDB8EFQ30450055-AE5C7C8E-FB4B-4B3D-AAAD-FE3BAFA07BDFQ33735269-448804E3-CEA1-4931-81BC-4B646AD935F3Q33925036-31099045-F77D-4414-9A2E-6EF2B3F00AE8Q33949491-B42C5FB2-C2FD-494D-A36A-4E0F8E2FAFA1Q34183517-7E546B69-D001-4BEE-80C9-B496A4CEDE52Q34563933-7D5A84FC-1EF9-4B66-A304-660061650D6DQ34580773-AA3A08E3-1939-491B-A46A-B51026CDA3EEQ35006462-6ED1F85E-0C24-462B-B8FA-B1EA897E218AQ35016781-D7EE598C-82E1-4693-B470-87D43BA924EFQ35066213-156D2686-F5E4-4B42-91DA-8FA748693A92Q35588407-023D5518-6DB4-4277-9ADC-D8E5B13EA9C1Q35995395-DD6229E6-2557-4984-9DEA-06B40FCF596DQ36157234-DF4DDE5A-E88F-4B14-B967-429A040A3F0FQ36249983-30CAFFD1-DD75-49DA-86D0-AA5846228593Q36284727-19BC17A1-7427-4008-8E0C-40CAB1ED627BQ36313119-D317C156-1005-4ABE-B8C0-1D6765C0A530Q36697463-2A923465-48BC-4CF8-8EB6-DAE8378C964FQ36742732-162C4F56-6ADF-4BBC-8C1F-D8F2AC8BF158Q36803417-BC6569AA-5164-47F1-ADCC-54419FE1BA3AQ36845975-3BB3601C-2281-4C74-B135-4C75DEA1F48DQ36974396-40A7A66D-8F8E-4CF0-8E7E-414334F3DDA8Q37129785-6F191F51-8A38-4A75-A799-1F31C729C3BAQ37156322-EA8292E0-351C-465E-A3EE-B3174CFDA473Q37180415-EC3B0308-0EB4-443D-8728-7DF902FEE64AQ37202953-9966D815-30FE-42F5-B3B8-FC0061F1DFF3Q37318734-7FFDFF72-C46E-4BE1-B041-1C514E50F956Q37594857-58560816-1BD2-4CC0-84DE-502AF797F3B0Q37658349-BFB87FB8-EA3B-4746-A740-852BE35C59EFQ37733552-6FBA2032-2EDF-4DD4-80E7-C19125586FC6Q37826193-DA833E43-A961-4B51-A3FE-0AFD3B202C40Q37832531-03A5DD01-59FC-47AA-B0E1-1D739D92B98CQ37841667-5D5403B0-F0FA-4D49-8021-75760F89E0F3Q37975526-982623E0-DAEA-4547-A21F-07D7C1B6C991Q38020929-EF998B6D-59BA-4DE8-8DBB-EC70FDF8AF52
P2860
Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures.
@en
Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures.
@nl
type
label
Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures.
@en
Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures.
@nl
prefLabel
Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures.
@en
Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures.
@nl
P2093
P1433
P1476
Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures.
@en
P2093
A R Kugler
E A Garofalo
J L Robbins
P304
P356
10.1212/01.WNL.0000068024.20285.65
P407
P577
2003-05-01T00:00:00Z